Results 251 to 260 of about 3,757,704 (310)
Statement of Retraction: Sufentanil alleviates pre-eclampsia via silencing microRNA-24-3p to target 11β-Hydroxysteroid dehydrogenase type 2. [PDF]
Bioengineeredeuropepmc +1 more source
<i>CPT1A, CYGB,</i> and <i>MRPL3</i> in pre-eclampsia: biomarkers identified from oxidative stress-related gene analysis. [PDF]
PeerJChen L, Wu M.
europepmc +1 more source
The Prediction of Pre-Eclampsia Using Low Fetal Fraction in a Machine Learning Model. [PDF]
Prenat DiagnWang J +9 more
europepmc +1 more source
Altered PAPP-A and Placental Thickness in Pre-Eclampsia and Intrauterine Growth Restriction: A Pilot Study. [PDF]
J Clin MedMoraru L +3 more
europepmc +1 more source
Lancet, The, 2010 Pre-eclampsia remains a leading cause of maternal and perinatal mortality and morbidity. It is a pregnancy-specific disease characterised by de-novo development of concurrent hypertension and proteinuria, sometimes progressing into a multiorgan cluster ...
Eric Steegers +2 more
exaly +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Lancet, The, 2021
(Abstracted from Lancet 2021;398:341–354) Preeclampsia affects approximately 3% to 5% of all pregnancies and is a substantial contributor to maternal morbidity and mortality. The hallmark features are hypertension and proteinuria, and significant complications of multiorgan injury include eclamptic seizures, pulmonary edema, epigastric pain ...
Lucy Chappell +2 more
exaly +3 more sources
(Abstracted from Lancet 2021;398:341–354) Preeclampsia affects approximately 3% to 5% of all pregnancies and is a substantial contributor to maternal morbidity and mortality. The hallmark features are hypertension and proteinuria, and significant complications of multiorgan injury include eclamptic seizures, pulmonary edema, epigastric pain ...
Lucy Chappell +2 more
exaly +3 more sources
Lancet, The, 2016
Pre-eclampsia affects 3-5% of pregnancies and is traditionally diagnosed by the combined presentation of high blood pressure and proteinuria. New definitions also include maternal organ dysfunction, such as renal insufficiency, liver involvement, neurological or haematological complications, uteroplacental dysfunction, or fetal growth restriction. When
Ben W. Mol +2 more
exaly +5 more sources
Pre-eclampsia affects 3-5% of pregnancies and is traditionally diagnosed by the combined presentation of high blood pressure and proteinuria. New definitions also include maternal organ dysfunction, such as renal insufficiency, liver involvement, neurological or haematological complications, uteroplacental dysfunction, or fetal growth restriction. When
Ben W. Mol +2 more
exaly +5 more sources
The Lancet, 2005
Pre-eclampsia is a major cause of maternal mortality (15-20% in developed countries) and morbidities (acute and long-term), perinatal deaths, preterm birth, and intrauterine growth restriction. Key findings support a causal or pathogenetic model of superficial placentation driven by immune maladaptation, with subsequently reduced concentrations of ...
Sibai, B., Dekker, G., Kupferminc, M.
openaire +3 more sources
Pre-eclampsia is a major cause of maternal mortality (15-20% in developed countries) and morbidities (acute and long-term), perinatal deaths, preterm birth, and intrauterine growth restriction. Key findings support a causal or pathogenetic model of superficial placentation driven by immune maladaptation, with subsequently reduced concentrations of ...
Sibai, B., Dekker, G., Kupferminc, M.
openaire +3 more sources
Obstetrical & Gynecological Survey, 1979
Summary: In a series of 26,209 patients, the incidence of pre‐eclampsia was 9.3%, being significantly higher in primiparae (14.1%) than multiparae (5.7%) (P<0.001). In patients with early‐onset pre‐eclampsia there were highly significant (P<0.001) increases in the incidences of proteinuria, severe hypertension, placental abruption, fetal growth ...
P A, Long, D A, Abell, N A, Beischer
openaire +2 more sources
Summary: In a series of 26,209 patients, the incidence of pre‐eclampsia was 9.3%, being significantly higher in primiparae (14.1%) than multiparae (5.7%) (P<0.001). In patients with early‐onset pre‐eclampsia there were highly significant (P<0.001) increases in the incidences of proteinuria, severe hypertension, placental abruption, fetal growth ...
P A, Long, D A, Abell, N A, Beischer
openaire +2 more sources